Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Effect on lymphocyte subsets of clotting factor therapy in human immunodeficiency virus-1-negative congenital clotting disorders. The Transfusion Safety Study Group.

Hassett J, Gjerset GF, Mosley JW, Fletcher MA, Donegan E, Parker JW, Counts RB, Aledort LM, Lee H, Pike MC.

Blood. 1993 Aug 15;82(4):1351-7.

2.

T-cell subsets in health, infectious disease, and idiopathic CD4+ T lymphocytopenia.

Laurence J.

Ann Intern Med. 1993 Jul 1;119(1):55-62. Review.

PMID:
8098929
3.

[Deep lung--cellular reaction to HIV].

Tavares Marques MA, Alves V, Duque V, Botelho MF.

Rev Port Pneumol. 2007 Mar-Apr;13(2):175-212. Review. Portuguese.

PMID:
17492233
4.

Transfusion therapy in congenital coagulopathies.

Lusher JM.

Hematol Oncol Clin North Am. 1994 Dec;8(6):1167-80. Review.

PMID:
7860443
5.

Immunological abnormalities in haemophiliacs.

Watson HG, Ludlam CA.

Blood Rev. 1992 Mar;6(1):26-33. Review.

PMID:
1586776
6.

The impact of clotting factor concentrates on the immune system in individuals with hemophilia.

Gomperts ED, de Biasi R, De Vreker R.

Transfus Med Rev. 1992 Jan;6(1):44-54. Review.

PMID:
1348008
7.

Blood transfusion: merits of component therapy. II. The clinical use of plasma and plasma components.

Buchholz DH.

J Pediatr. 1974 Feb;84(2):165-72. Review. No abstract available.

PMID:
4589841
8.

Acquired and congenital clotting syndromes.

Blaisdell FW.

World J Surg. 1990 Sep-Oct;14(5):664-9. Review.

PMID:
2238669
9.

Surgery in congenital disorders of blood coagulation.

Britten AF, Salzman EW.

Surg Gynecol Obstet. 1966 Dec;123(6):1333-58. Review. No abstract available.

PMID:
5333478

Supplemental Content

Support Center